We speculate the LTβR-mediated enhancement of proliferation is augmenting progression and skewing the pathological appearance of AKT/CAT-associated tumour phenotypes, such as ICC-like lesions. The gene discussed is CAT; the disease is intrahepatic cholangiocarcinoma.